Merck & Co. Net revenues
Net Revenue of Merck & Co. 2006-2021
Amounts are in $ millions.
| Year | Net Revenues ($m) |
| 2021 | $48,704 |
| 2020 | $41,518 |
| 2019 | $39,121 |
| 2018 | $ 42,294 |
| 2017 | $ 40,122 |
| 2016 | $ 39,807 |
| 2015 | $ 39,498 |
| 2014 | $ 42,237 |
| 2013 | $ 44,033 |
| 2012 | $ 47,267 |
| 2011 | $ 48,047 |
| 2010 | $ 45,987 |
| 2009 | $ 27,428 |
| 2008 | $ 23,850 |
| 2007 | $24,198 |
| 2006 | $22,636 |
2021: The net revenues of Merck & Co increased by 17% in 2021 compared to the previous year. Its total net revenues in 2021 grew to $48,704 million compared to $41,518 million in 2020. The company's net revenues in 2021 grew across both the US and international markets compared to 2020. Its US revenues for 2021 reached $22,425 million or 14% higher than the prvious year when its sales in the US were $19,588 million. The international revenues of the company reached $26,279 million in 2021 compared to $21,930 million in 2020 or an annual growth of 20%.
2018: Net Revenue of Merck & Co rose to $42.3 billion in 2018 from $40.1 billion in 2017.
Merck & Co., Inc. (Merck or the Company) is a global health care company.It provides innovative health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. The Company’s operations are mainly managed on a products basis. Its business operations include four operating segments, which are the Pharmaceutical, Animal Health, Healthcare Services and Alliances segments.